General Announcement::Rating by S&P Global Ratings

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
01-Mar-2018 20:33:14
Status
New
Announcement Sub Title
Rating by S&P Global Ratings
Announcement Reference
SG180301OTHR30OJ
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
01/03/2018 17:00:00
Description (Please provide a detailed description of the event in the box below)
Sub:- Rating by S&P Global Ratings

With reference to the above subject, we have to inform you that our credit rating has been revised by S&P Global Ratings from BB to BB- as part of their review cycle. They have revised the outlook from Negative to Stable .

In addition, they have revised the rating on the senior unsecured notes issued in 2016 from BB to BB- .

Kindly find enclosed rating research update issued by S&P Global for your reference.

Attachments

SGX Press Release.pdf
Total size =702K